SEC Form 3 · accession 0000899243-18-027001
LogicBio Therapeutics, Inc. · LOGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederic Chereau
Officer — See Remarks · Director
Period of report
Oct 18, 2018
Accepted (ET)
Oct 18, 2018 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001664106
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 237,939 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.73 | holding | — | — | — | — | Nov 2, 2027 | Common Stock | 547,000 | — | D |
Explanation of responses
- F1The option vests over the first forty-eight months after the vesting commencement date, June 19, 2017.
Remarks
President and Chief Executive Officer Exhibit List Exhibit 24 - Power of Attorney